English
Regional settings| Spread | 1.5 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ SEK 5,000.00 Short position overnight fee ~ SEK 4,000.00 | -0.02194% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ SEK 5,000.00 Short position overnight fee ~ SEK 4,000.00 | -0.000282% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | SEK | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | Sweden | ||||
| Commission on trade1 | 0% |
Information_provided_by_capital
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 113.9 |
| Open | 113.7 |
| 1-Year Change | 22.13% |
| Day's Range | 113.3 - 114.7 |
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
BRIEF: For the fiscal year ended 31 December 2021, BioGaia AB revenues increased 5% to SEK785.1M. Net income increased 9% to SEK196.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Other operating expenses/operating incom decrease from SEK17.4M (expense) to SEK11.2M (income). Dividend per share increased from SEK6.82 to SEK7.26.
